期刊文献+

葛根素对冠心病患者胰岛素抵抗及内皮纤溶功能的影响 被引量:5

Effect of Puerarin on insulin resistance and fibrinolysis function of patients with caronary heart disease
下载PDF
导出
摘要 将 72例冠心病 (CHD)患者随机分为常规组 (3 3例 )和葛根素组 (3 9例 ) ,均于治疗前及治疗结束时检测其血糖、胰岛素、纤溶指标 ,计算胰岛素敏感性指数 (ISI) ,并行静脉闭塞试验 (VOT) ;同时选择 3 0例健康人作为对照组。结果显示 :1与对照组比较 ,CHD患者的血浆胰岛素 (FINS)浓度增高 (P<0 .0 1) ,ISI降低 (P<0 .0 5 ) ,VOT前及 VOT时内皮组织型纤溶酶原激活物 (t- PA)活性降低 (P<0 .0 1) ,纤溶酶原激活物抑制物 - 1(PAI- 1)活性增高 (P<0 .0 1)。 FINS、ISI与纤溶指标存在高度线性相关意义。 2葛根素组治疗后 FINS、PAI- 1下降(P<0 .0 1) ,ISI、VOT前及 VOT时 t- PA增高 (P<0 .0 5、<0 .0 1) ,与常规组治疗后比较均具有显著性差异(P<0 .0 5、<0 .0 1)。认为葛根素能改善 CHD患者的胰岛素抵抗 (IR) patients with coronary heart disease (CHD) were randomly divided into the routine treated group (33 cases) and puerarin treated group (39 cases).The fasting blood glucose (FBG),fasting plasma insulin (FINS) were measured before and after treatment.Insulin sensitivity index (ISI) was calculated.The fibrinolytic parameters were observed before and during venous occlusion test (VOT).30 healthy subjects were taken for controls.Result showed that the FINS and plasminogen activator inhibitor-1 (PAI-1) levels were higher ( P<0.01),the ISI and tissue-type plasminogen activator (t-PA) before and during VOT were lower (P<0.05, P<0.01) in CHD patients than those in healthy controls.FINS and ISI were associated with fibrinolytic parameters.After puerarin treatment,the FINS and PAI-1 was decreased (P<0.01),ISI and t-PA before and during VOT were increased (P<0.05,P<0.01) in puerarin group.While comparing with the routine group,the differences were significant (P<0.05,P<0.01).This suggests that insulin resistance (IR) and the disturbances of fibrinolysis related closely with IR in CHD patients could be effectively improved by puerarin.
出处 《山东医药》 CAS 北大核心 2003年第1期9-11,共3页 Shandong Medical Journal
关键词 冠状动脉疾病 葛根素 胰岛素抵抗 纤溶 治疗 Coronary heart disease Puerarin Insulin resistance Fibrinolysis
  • 相关文献

参考文献7

  • 1Negri M,Sheiban I,Arigliano PL,et al.Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin,C-peptide and plasminogen activator inhibitor-1.Am J Cardiol,1993,72:397~401.
  • 2Pyoo. .ra. .la. . M,Miettinen H,Laakso M,et al.Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men.Circulation,1998,98:398~404.
  • 3李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 4Francis RB,Kawanishi D,Baruch T,et al.Impaired fibrinolysis in coronary artery disease.Am Heart J,1988,115:776~780.
  • 5Nordt TK,Sawa H,Fujii S,et al.Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.J Mol Cell Cardiol,1998,30:1535~1543.
  • 6Juhan VI,Pyke SDM,Alessi MC,et al.Fibrinolytic and the risk of myocardial infarction or sudden death in patients with angina pectoris.Circulation,1996,94:2057~2063.
  • 7岳红文,胡小琴.葛根及葛根素对心血管系统的药用价值[J].中国中西医结合杂志,1996,16(6):382-384. 被引量:156

二级参考文献16

  • 1范礼理,Chin Med J,1992年,105卷,1期,11页
  • 2朱志敏,生物化学杂志,1992年,5卷,1期,61页
  • 3辛洪波,中国病理生理杂志,1991年,7卷,2期,199页
  • 4张国君,中西医结合杂志,1990年,10卷,2期,82页
  • 5姜秀莲,药学学报,1989年,24卷,4期,251页
  • 6李小鹰,中华心血管病杂志,1985年,13卷,3期,175页
  • 7范礼理,药学学报,1984年,19卷,11期,801页
  • 8吕欣然,药学学报,1980年,15卷,4期,218页
  • 9朱秀媛,药学学报,1979年,14卷,6期,349页
  • 10曾贵云,中华医学杂志,1979年,59卷,8期,479页

共引文献2275

同被引文献83

引证文献5

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部